SEPTInvestingStart Free

HELP SCHEDULE 13G/A: SEC filing

Millennium Management LLC and affiliated entities

Filed with the SEC on · accession 0001104659-26-126356

HELP filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 12, 2026. Millennium Management LLC and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 1.4% of Helus Pharma Inc.'s common shares as of September 30, 2026. The stock moved -5.6% by the first close after the filing.

Summary of the filing

Millennium Management LLC and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 1.4% of Helus Pharma Inc.'s common shares as of September 30, 2026. The filing is a passive investment disclosure with no intent to influence control of the company.

For details, click here →

Key details

Common shares beneficially owned by Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander$1.0M
Common shares beneficially owned by Integrated Core Strategies (US) LLC$689K
Issuer of the securitiesHelus Pharma Inc.
Reporting beneficial owner (1.4%)Millennium Management LLC
Managing member of millennium management llc; reporting beneficial owner (1.4%)Millennium Group Management LLC
Reporting beneficial owner (0.9%)Integrated Core Strategies (US) LLC
Sole voting trustee of the managing member of millennium group management llcIsrael A. Englander
Global general counsel, millennium management llcGil Raviv

How HELP stock reacted

Close before

$9.39

Nov 11, 2026

First close after

-5.64%

$8.86

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for HELP, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for HELP?

Click here

Frequently asked questions

What did HELP file with the SEC on Nov 12, 2026?

HELP filed a SCHEDULE 13G/A (SEC filing). Millennium Management LLC and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 1.4% of Helus Pharma Inc.'s common shares as of September 30, 2026. The filing is a passive investment disclosure with no intent to influence control of the company.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did HELP stock react to this filing?

HELP closed at $9.39 before the filing and $8.86 on Nov 12, 2026 (-5.64%).

Other HELP SEC filings

Get alerts when HELP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
HELP overviewHELP analysisHELP newsLatest SEC filings